Free Trial

Cabaletta Bio (CABA) SEC Filings & 10K Form

Cabaletta Bio logo
$2.38 +0.07 (+3.03%)
(As of 12/20/2024 05:45 PM ET)

Recent Cabaletta Bio SEC Filings

DateFilerForm TypeView
12/05/2024
3:50 PM
Cabaletta Bio (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
12/05/2024
2:36 PM
Cabaletta Bio (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
11/18/2024
6:05 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Cabaletta Bio (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:02 PM
ALGER ASSOCIATES INC (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
11/14/2024
6:07 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:14 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
11/04/2024
11:01 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:38 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:38 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:00 AM
Cabaletta Bio (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/07/2024
5:06 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:30 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
5:10 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cabaletta Bio (Subject)
Form SC 13G
08/08/2024
6:25 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:07 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:06 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
12:01 PM
Cabaletta Bio (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G
06/04/2024
6:27 PM
Bollard Catherine (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:14 PM
Cabaletta Bio (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:17 PM
Brun Scott C. (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:21 PM
Cabaletta Bio (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:21 PM
Cabaletta Bio (Issuer)
Simon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:32 PM
Cabaletta Bio (Filer)
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:53 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
6:04 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
6:00 AM
Cabaletta Bio (Filer)
Form DEF 14A
04/23/2024
6:05 AM
Cabaletta Bio (Filer)
Form DEFA14A
04/23/2024
6:10 AM
Cabaletta Bio (Filer)
Form ARS
03/21/2024
7:02 AM
Cabaletta Bio (Filer)
Form S-3ASR
03/21/2024
6:51 AM
Cabaletta Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:24 AM
Cabaletta Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
6:12 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
6:11 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
4:45 PM
Cabaletta Bio (Issuer)
Chang David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:50 PM
Cabaletta Bio (Issuer)
Gerard Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:36 PM
Cabaletta Bio (Issuer)
Das Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:36 PM
Cabaletta Bio (Issuer)
Marda Anup (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:40 PM
Cabaletta Bio (Issuer)
Nichtberger Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:28 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
02/14/2024
7:53 PM
Cabaletta Bio (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
8:20 AM
Cabaletta Bio (Subject)
Lynx1 Capital Management LP (Filed by)
Form SC 13G/A
02/13/2024
5:47 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
02/12/2024
4:25 PM
Cabaletta Bio (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/07/2024
6:04 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
02/01/2024
3:36 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:07 AM
Cabaletta Bio (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/19/2024
5:30 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G
01/08/2024
6:11 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CABA) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners